| Dr Sarah Elizabeth Cates, DO | |
|
750 Townpark Lane, Kaiser Permanente Townpark Comprehensive Medical Center, Kennesaw, GA 30144 | |
| (770) 514-5401 | |
| Not Available |
| Full Name | Dr Sarah Elizabeth Cates |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 750 Townpark Lane, Kennesaw, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740455179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 66268 (Georgia) | Secondary |
| 207P00000X | Emergency Medicine | 066268 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
News Archive
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.
Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer's to spread through the brain.
› Verified 5 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.
Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer's to spread through the brain.
› Verified 5 days ago
| Entity Name | Western Healthcare Services Kentucky Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770243842 PECOS PAC ID: 0941695936 Enrollment ID: O20220309001033 |
News Archive
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.
Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer's to spread through the brain.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Elizabeth Cates, DO 3495 Piedmont Road, Ne, Nine Piedmont Center, Atlanta, GA 30305 Ph: (404) 364-7070 | Dr Sarah Elizabeth Cates, DO 750 Townpark Lane, Kaiser Permanente Townpark Comprehensive Medical Center, Kennesaw, GA 30144 Ph: (770) 514-5401 |
News Archive
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
ZymoGenetics, Inc. today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection. ZymoGenetics is developing the investigational compound PEG-Interferon lambda in collaboration with Bristol-Myers Squibb Company.
A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.
Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer's to spread through the brain.
› Verified 5 days ago
Dr. Dorland Brown, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3805 Cherokee St Nw, Kennesaw, GA 30144 Phone: 770-426-5665 Fax: 770-420-1792 | |
Dr. Charles Hoff, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3805 Cherokee St Nw, Kennesaw, GA 30144 Phone: 770-426-5665 Fax: 770-420-1792 | |
Dr. Kathleen Marie Gunchick, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 Chastain Road Md 5200 House 52, Kennesaw State University Health Clinic, Kennesaw, GA 30144 Phone: 770-423-6644 | |
Dr. Dareema Hughes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Townpark Ln Nw, Kaiser Permanente Townpark Comprehensive Medical Center, Kennesaw, GA 30144 Phone: 770-514-5401 | |
Dr. Aarthi Sridhar, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Townpark Ln Nw, Kaiser Permanente Town Park Comprehensive Medical Cente, Kennesaw, GA 30144 Phone: 770-514-5401 | |
Dr. Christy Francis Hewling, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Townpark Ln Nw, Kennesaw, GA 30144 Phone: 404-365-0966 | |
Jannet R Scruggs, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 750 Townpark Lane, Kaiser Permanente Townpark Medical Office, Kennesaw, GA 30144 Phone: 770-514-5401 Fax: 478-454-3969 |